ロード中...
The challenge of Helicobacter pylori resistance to antibiotics: the comeback of bismuth-based quadruple therapy
A proton-pump inhibitor (PPI), clarithromycin-based, triple therapy has been the recommended treatment for Helicobacter pylori eradication for the past 15 years. Due to a steady increase in H. pylori resistance to clarithromycin, this triple clarithromycin-based treatment has become progressively le...
保存先:
| 第一著者: | |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
SAGE Publications
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3296089/ https://ncbi.nlm.nih.gov/pubmed/22423259 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1756283X11432492 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|